Cases
Representative Matters: Represented a SaaS (BI) company located in San Francisco, in its Series A, Series B
Series C Preferred Stock financings,
in an all cash acquisition of the company by an acquiror located in the Bay area.
Represented a Los Angeles area SaaS company in its acquisition of a company located on the East Coast in a stock for stock transaction.
Represents a leading California angel group in the group's investments in companies located on the West Coast.
Represented European based biotech company, focused on drug delivery solutions, with respect to its inbound
outbound licensing transactions
those related to the development, manufacture
supply of key components of its technologies.
Represents company that invests in, develops
operates solar
wind power generating projects, including the investments made by the company,
the sale of various projects to large developers.
Represented biomarker company in its seed
Series A Preferred Stock funding,
multiple licenses for platforms related thereto.
Represented privately held Palo Alto based SEM company in its Series A
Series B Preferred stock financings
the acquisition of the company by a private equity group.
Represents high net worth
angel investors
venture capital funds in initial
follow on debt
equity financing transactions.
Represented privately-held San Diego-based technology company with over 150 shareholders in a 30M cash for stock transaction.
Represented privately held San Diego medical device company in its Series B
Series C Preferred Stock financing in which 19M
30M, respectively, was raised.
Represented San Diego based CRM technology company in its seed, Series A, Series A-1
Series B Preferred Stock financings.
Represented Carlsbad based SaaS company in its Series A
Series B Preferred Stock financing, the filing of a Permit Application with the California Department of Corporations
the reincorporation into Delaware related thereto.
Represented public telecommunications company in 80M cash sale of its semiconductor subsidiary located in Scotts Valley, CA
a 65M cash sale of its telecommunications subsidiary located in Gaithersburg, MD.
Represented San Diego-based medical device company in its simultaneous acquisition of three private companies.
Represented San Diego technology company in its acquisition by a public company, in a 50M cash for stock transaction.
Represented public Canadian company, in its acquisition of a public telecommunications company in a 750M stock-for-stock transaction.
Represented public medical device company in a 500M stock-for-stock merger.
Represented medical device
biotechnology companies in initial incorporation
multiple rounds of Preferred Stock financing.
Represented a pharmaceutical company in its Series B
Series C Preferred Stock financing in which 5M
30M, respectively, was raised.
Represented two biotechnology venture capital funds (co-lead investors), investing in a drug development company in a 45M purchase
sale of Series D Preferred Stock.
Represented venture capital fund in its investment
purchase of preferred stock of various life science companies in which it is lead investor.
Represented Seattle based company in a 21M PIPE offering.
Represented technology company in its initial public offering, raising 65M from the sale of common stock shares.
Represented software company in its proposed 40M offering of common stock, preferred stock, warrants
/or units under a universal shelf registration statement on Form S-3.
Represented public companies on a variety of matters, including general issues related to corporate governance
the drafting of periodic reports.
Represented Los Angeles based SaaS company in its conversion from an LLC to a C corporation,
the simultaneous reorganization
Series A Preferred Stock financing.
Represented a San Diego technology company in the negotiation
spin-off of certain assets
the establishment of a joint venture with a publicly traded company located in New York to produce trading cards, an animated cartoon series,
merch
ising rights related thereto. TESTIMONIALS "For the past decade, through multiple rounds of financing,
ultimately leading to the FDA's approval of our Banyan BTI, we've counted on Procopio
Partner Roger Rappoport for critical legal guidance
counsel. When your venture aims to do something no one has done before-in our case, develop
commercialize the first-ever in vitro diagnostic blood test to aid in the evaluation of patients with suspected TBI, also known as concussion-you want an attorney
a law firm that will take the time to underst
your unique needs
clear legal roadblocks before you can even anticipate them. That's what we've come to rely on with Roger
Procopio." -- Steven P. Richieri, President/COO, Banyan Biomarkers, Inc. Roger Rappoport brought immense practical, legal
business experience to his work, delivered with the highest integrity, diligence
value. Roger's personal approach brought a refreshing style to his interactions with me, our board, bankers
employees. I strongly recommend Roger
Procopio if you are an emerging technology CEO in search of an experienced outside corporate counsel. -- Craig Brennan, CEO, Overtone, Inc. (acquired by KANA Software, Inc.)
